Literature DB >> 30694659

Discovery of Myricetin as a Potent Inhibitor of Human Flap Endonuclease 1, Which Potentially Can Be Used as Sensitizing Agent against HT-29 Human Colon Cancer Cells.

Long Ma1, Xiuqi Cao1, Haiyue Wang1, Kui Lu1, Ying Wang1, Chunhao Tu1, Yujie Dai1, Yuanyuan Meng1, Yuyin Li1, Peng Yu1, Shuli Man1, Aipo Diao1.   

Abstract

Human flap endonuclease 1 (hFEN1) is instrumental in DNA replication and repair. It is able to cleave the 5' single-stranded protrusion (also known as 5' flap) resulting from strand displacement reactions. In light of its crucial functions, hFEN1 is now deemed as a nontrivial target in the DNA damage response system for anticancer drug development. Herein, we report that myricetin and some natural flavonoids are able to inhibit hFEN1. Structure-activity relationship, inhibitory mechanisms, molecular docking, and cancer cell-based assays have been performed. Our original findings expand the activity of flavonoids and may pave the way for flavonoid-assisted targeted cancer therapy.

Entities:  

Keywords:  colon cancer treatment; flavonoids; human flap endonuclease 1 (hFEN1); inhibitor; molecular docking; myricetin; sensitizing effect; structure−activity relationship analysis

Mesh:

Substances:

Year:  2019        PMID: 30694659     DOI: 10.1021/acs.jafc.8b05447

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  15 in total

Review 1.  A review on myricetin as a potential therapeutic candidate for cancer prevention.

Authors:  Nazia Afroze; Sreepoorna Pramodh; Arif Hussain; Madiha Waleed; Kajal Vakharia
Journal:  3 Biotech       Date:  2020-04-24       Impact factor: 2.406

2.  Myricetin Induces Apoptosis and Protective Autophagy through Endoplasmic Reticulum Stress in Hepatocellular Carcinoma.

Authors:  Anlai Ji; Lili Hu; Ding Ma; Guanghui Qiang; Dongliang Yan; Guang Zhang; Chunping Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-29       Impact factor: 2.650

3.  Dual Processing of R-Loops and Topoisomerase I Induces Transcription-Dependent DNA Double-Strand Breaks.

Authors:  Agnese Cristini; Giulia Ricci; Sébastien Britton; Simona Salimbeni; Shar-Yin Naomi Huang; Jessica Marinello; Patrick Calsou; Yves Pommier; Gilles Favre; Giovanni Capranico; Natalia Gromak; Olivier Sordet
Journal:  Cell Rep       Date:  2019-09-17       Impact factor: 9.423

4.  Jianpi-yangwei decoction inhibits DNA damage repair in the drug resistance of gastric cancer by reducing FEN1 expression.

Authors:  Wenjie Huang; Huijuan Tang; Fang Wen; Xiaona Lu; Qingpei Li; Peng Shu
Journal:  BMC Complement Med Ther       Date:  2020-06-26

5.  miR-193b Increases the Chemosensitivity of Osteosarcoma Cells by Promoting FEN1-Mediated Autophagy.

Authors:  Suwei Dong; Yanbin Xiao; Xiang Ma; Wei He; Jianping Kang; Zhuohui Peng; Lei Wang; Zhen Li
Journal:  Onco Targets Ther       Date:  2019-11-22       Impact factor: 4.147

6.  Total flavone extract from Ampelopsis megalophylla induces apoptosis in the MCF‑7 cell line.

Authors:  Chun Gui; Chao Zhang; Xiaomei Xiong; Jing Huang; Juan Xi; Ling Gong; Bisheng Huang; Xiuqiao Zhang
Journal:  Int J Oncol       Date:  2021-01-15       Impact factor: 5.650

7.  Evaluation of Indonesian mangrove Xylocarpus granatum leaves ethyl acetate extract as potential anticancer drug.

Authors:  Jason Darmadi; Razethy Rahayu Batubara; Sandiego Himawan; Norma Nur Azizah; Hilyatushalihah Kholis Audah; Ade Arsianti; Evi Kurniawaty; Intan Safinar Ismail; Irmanida Batubara; Kholis Abdurachim Audah
Journal:  Sci Rep       Date:  2021-03-16       Impact factor: 4.379

8.  The Clinical Significance of the Expression of FEN1 in Primary Osteosarcoma.

Authors:  Guangxian Zhong; Yunqing Wang; Hongxiang Wei; Meifang Chen; Huangfeng Lin; Zhen Huang; Jinlong Huang; Shenglin Wang; Jianhua Lin
Journal:  Int J Gen Med       Date:  2021-10-07

Review 9.  Molecular Pathways Involved in the Anti-Cancer Activity of Flavonols: A Focus on Myricetin and Kaempferol.

Authors:  Maria Rosa Felice; Alessandro Maugeri; Giovambattista De Sarro; Michele Navarra; Davide Barreca
Journal:  Int J Mol Sci       Date:  2022-04-16       Impact factor: 6.208

Review 10.  Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications.

Authors:  Yasaman Taheri; Hafiz Ansar Rasul Suleria; Natália Martins; Oksana Sytar; Ahmet Beyatli; Balakyz Yeskaliyeva; Gulnaz Seitimova; Bahare Salehi; Prabhakar Semwal; Sakshi Painuli; Anuj Kumar; Elena Azzini; Miquel Martorell; William N Setzer; Alfred Maroyi; Javad Sharifi-Rad
Journal:  BMC Complement Med Ther       Date:  2020-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.